IP Library Granted Patent US 8,748,372
Granted Patent B2
US 8,748,372 · App. 13/331,363 · Granted Jun 10, 2014

Polynucleotide encoding a TRIM-cyp polypeptide, compositions thereof, and methods of using same

Inventors: Jeremy Luban (New York, NY); David Sayah (San Francisco, CA)
Assignee: The Trustees of Columbia University in the City of New York
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,748,372
App. No.
13/331,363
Granted
Jun 10, 2014
Kind
B2
Abstract

The invention provides an isolated nucleic acid encoding a TRIM-cyclophilin A fusion sequence encoding a TRIMcyp fusion protein which is active as an anti-viral agent, and in particular an anti-HIV-1 agent. The invention provides for a nucleic acid encoding a polypeptide having both TRIM activity and cyclophilin activity. The invention provides for an isolated polynucleotide encoding a TRIM-cyclophilin fusion protein, or variants thereof retaining the TRIM and cyclophilin activities. The invention provides for compositions thereof, antibodies that specifically bind thereto, and vectors and host cells comprising the nucleic acid or polypeptide. In addition, the invention provides for methods for treating or preventing viral infection, or reducing viral load in a subject comprising administering the nucleic acid, polypeptide, vector, or composition to the subject in an amount effective to treat or prevent the viral infection.

Claims (10)

1. An isolated polypeptide comprising the amino acid sequence of SEQ ID NO:4.

2. An isolated polypeptide consisting essentially of the amino acid sequence of SEQ ID NO:4.

3. An isolated polypeptide comprising an amino acid sequence at least about 85% identical to SEQ ID NO: 4.

4. The isolated polypeptide of claim 3 , wherein the polypeptide comprises an amino acid sequence at least about 90% identical to SEQ ID NO: 4.

5. The isolated nucleic acid of claim 3 , wherein the polypeptide comprises an amino acid sequence at least about 95% identical to SEQ ID NO: 4.

6. An isolated cell comprising the polypeptide of claim 1 , 2 , 3 , 4 or 5 .

7. An isolated stem cell comprising the polypeptide of claim 1 , 2 , 3 , 4 or 5 .

8. A method for inhibiting HIV-1 in a subject, comprising administering to the subject an isolated TRIM-cyclophilin polypeptide of claim 1 or 2 .

9. A composition comprising the polypeptide of claim 1 , 2 , 3 , 4 or 5 .

10. The composition of claim 9 , wherein the carrier comprises a liposome.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 13, 2017
From: COLUMBIA UNIV NEW YORK MORNINGSIDE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042776/0125 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2011
From: LUBAN, JEREMY; SAYAH, DAVID
To: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
Reel/Frame 027429/0433 →
Continuity (4)
Division 11650384 · Jan 5, 2007
Continuation PCTUS2005023803 · Jul 6, 2005
Provisional Application 60585925 · Jul 6, 2004
Related Publication 20130084327A1 · Apr 4, 2013